Gsk Plc-Spon Adr
GSKHeld by 8 superinvestors.
SEC 13F · holders
Superinvestors Holding This Security
8 holders · $2.76B combined · this quarter +0 opened / -0 exited
- Value$2.53BWeight (prev→now)1.8% → 1.3% ▼
- Value$188.7MWeight (prev→now)0.5% → 0.4% ▼
- Value$26.4MWeight (prev→now)0.2% → 0.1% ▼
- Value$8.9MWeight (prev→now)1.6% → 1.6%
- Value$4.8MWeight (prev→now)3.7% → 3.5% ▼
- Value$4.3MWeight (prev→now)0.4% → 0.3% ▼
- Value$1.3MWeight (prev→now)0.0% → 0.0% ▲
- Value$375,470Weight (prev→now)0.0% → 0.0% ▼
SEC 13F · notes
Written summary
Written summary
Gsk Plc-Spon Adr (GSK) is held by 8 of the superinvestors tracked on Compounder, with a combined $2.76B in reported 13F value. The largest position belongs to Dodge & Cox, where it makes up 1.3% of the portfolio.
Other notable holders by value include Jeremy Grantham (0.4% of its book), Ray Dalio (0.1% of its book) and Thomas Kahn (1.6% of its book).
Over the latest quarter, 0 of the tracked filers opened a new position in GSK, 2 added to existing ones, 5 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
SEC 13F · co-ownership
Also held by these investors
Investors holding Gsk Plc-Spon Adr (GSK) also commonly hold →
- Walt Disney Co/TheDIS8 holders
- Microsoft CorpMSFT7 holders
- Pfizer IncPFE7 holders
- Alphabet Inc-Cl AGOOGL6 holders
- Unitedhealth Group IncUNH6 holders
- Alphabet Inc-Cl CGOOG6 holders
See which stocks look cheap against a conservative value band. Browse all valued stocks
Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-14
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Stay Updated
New-quarter 13F moves and valuation updates, to your inbox.